Program of Screening, Prevention and Elimination of Hepatitis C in Penitentiary Institutions in Cantabria (JAILFREE-C)
Status:
Completed
Trial end date:
2017-05-10
Target enrollment:
Participant gender:
Summary
The objectives of this study are:
1. To perform a systematic screening and evaluation of the prevalence of infection by
hepatitis C virus (HCV), hepatitis B virus (HBV) and human immunodeficiency virus (HIV)
in the prison population.
2. To perform an adequate characterization of patients and the characteristics of HCV
infection in this population.
3. To evaluate the effectiveness and security in the prison population of an
interferon-free antiviral regimen.
4. To evaluate the impact of a strategy of systematic HCV treatment on the rates of
persistent infection, reinfection and super-infection in a prison population, in the
short, medium and long term.
Phase:
Phase 4
Details
Lead Sponsor:
Instituto de Investigación Marqués de Valdecilla
Treatments:
Ledipasvir Ledipasvir, sofosbuvir drug combination Ribavirin Sofosbuvir